Circulating 25-Hydroxyvitamin D and Risk of Esophageal and Gastric Cancer Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

National Cancer Institute, Bethesda, Maryland 20852, USA.
American journal of epidemiology (Impact Factor: 4.98). 07/2010; 172(1):94-106. DOI: 10.1093/aje/kwq121
Source: PubMed

ABSTRACT Upper gastrointestinal (GI) cancers of the stomach and esophagus have high incidence and mortality worldwide, but they are uncommon in Western countries. Little information exists on the association between vitamin D and risk of upper GI cancers. This study examined the association between circulating 25-hydroxyvitamin D (25(OH)D) and upper GI cancer risk in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Concentrations of 25(OH)D were measured from 1,065 upper GI cancer cases and 1,066 age-, sex-, race-, and season-of blood draw-matched controls from 8 prospective cohort studies. In multivariate-adjusted models, circulating 25(OH)D concentration was not significantly associated with upper GI cancer risk. Subgroup analysis by race showed that among Asians, but not Caucasians, lower concentrations of 25(OH)D (<25 nmol/L) were associated with a statistically significant decreased risk of upper GI cancer (reference: 50-<75 nmol/L) (odds ratio = 0.53, 95% confidence interval: 0.31, 0.91; P trend = 0.003). Never smokers with concentrations of <25 nmol/L showed a lower risk of upper GI cancers (odds ratio = 0.55, 95% confidence interval: 0.31, 0.96). Subgroup analyses by alcohol consumption produced opposing trends. Results do not support the hypothesis that interventions aimed at increasing vitamin D status would lead to a lower risk of these highly fatal cancers.

Download full-text


Available from: Yu-Tang Gao, Aug 18, 2015
  • Source
    • "Although a number of studies have investigated associations between serum vitamin D levels and various cancers (Garland and Garland, 1980; Chen et al, 2007; Li et al, 2007; Abbas et al, 2008; Ahn et al, 2008; Abnet et al, 2010; Jenab et al, 2010; Stolzenberg- Solomon et al, 2010), little epidemiologic data for vitamin D and liver cancer are available, despite the important role of the liver in metabolising the circulating form of vitamin D. Supporting a possible association, vitamin D has been shown to inhibit liver carcinogenesis in cell lines and several animal models (Ghous et al, 2008), for example, vitamin D has been shown to reduce the number of chromosomal aberrations and double-strand breaks (Saha et al, 2001) as well as prevent cellular proliferation (Pourgholami et al, 2000; Caputo et al, 2003). For liver disease, results from existing epidemiologic studies, each modest in size, are mixed. "
    [Show abstract] [Hide abstract]
    ABSTRACT: C-reactive protein (CRP) is a marker of systemic inflammation that has been associated with the incidence and prognosis for a number of different cancers. Recent data suggest that CRP may be a prognostic factor for liver cancer and cirrhosis. However, few long-term studies are available. We prospectively examined associations between serum CRP and subsequent risk of liver cancer incidence or chronic liver disease mortality in a nested case-control study performed in the Linxian Nutrition Intervention Trials cohort. Baseline serum CRP was measured for 220 incident liver cancer cases, 276 participants who died of chronic liver disease, and 1,018 age-, sex-, and trial-matched controls. Unconditional logistical regression models were used to estimate ORs and 95% confidence intervals (CI). Compared with the lowest quartile, subjects in the fourth quartile of serum CRP had a higher risk of liver cancer incidence (OR, 1.63; 95% CI, 1.06-2.51), with a significant Ptrend across quartiles (P = 0.01). The association with liver cancer was only significant among men (Q4 vs. Q1; OR, 2.00; 1.10-3.62), but not among women (Q4 vs. Q1; OR, 1.15; 0.60-2.22). For chronic liver disease deaths, the corresponding risk estimate in men and women was 2.95 (1.90-4.57), with a monotonic trend (P < 0.001). Higher serum CRP concentrations at baseline were associated with subsequent incidence of liver cancer and death from chronic liver disease. Our findings suggest that levels of systemic inflammation may serve as a long-term marker of liver cancer and liver disease. Cancer Epidemiol Biomarkers Prev; 24(2); 1-7. ©2015 AACR. ©2015 American Association for Cancer Research.
    British Journal of Cancer 09/2013; 109(7). DOI:10.1038/bjc.2013.546 · 4.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The World Cancer Research Fund/American Institute for Cancer Research Report on the role of diet in cancer development was published in 2007 and provides the best evidence to date on the subject. This review highlights some recent findings that add to our understanding or raise some questions. The evidence is convincing that body fatness increases cancer risk, including postmenopausal breast cancer; however, recent data indicate that the relationship is heterogeneous by subtype of breast cancer. High plasma vitamin D levels were previously thought to reduce cancer risk, and although recent evidence supports this association for some cancer sites, it also provides evidence of an increased risk of some rarer cancers, including pancreatic and esophageal cancer. Research that adds to our understanding of the association between colorectal cancer risk, fruit and vegetable intake, and also folate and colorectal cancer risk during time periods before and after folic acid fortification is also highlighted.
    03/2012; 1(1). DOI:10.1007/s13668-011-0002-y
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (VDPP) brought together 10 cohorts to conduct a prospective study of the association between vitamin D status, measured as serum concentrations of 25-hydroxyvitamin D (25(OH)D), and the development of 7 rarer cancer sites: endometrial, esophageal, gastric, kidney, non-Hodgkin lymphoma, ovarian, and pancreatic cancers. The cohorts come from 3 continents, with participants from a wide range of latitude who are racially diverse. Across each cancer site, there was no evidence of a protective association between higher concentrations of 25-hydroxyvitamin D (>75 nmol/L) and cancer outcome. An increased risk at very high levels (> or =100 nmol/L) was noted for pancreatic cancer, confirming previous reports. The articles included in this issue detail the overall design and governance of the project, correlates of vitamin D status, and results from the cancer site-specific investigations. The Vitamin D Pooling Project realizes a major goal of consortium efforts, namely, to rigorously test hypotheses for rarer cancer outcomes that may not be adequately addressed in any one prospective cohort study. The results of this study have application for the planning and conduct of intervention trials, especially in determining potential risks.
    American journal of epidemiology 07/2010; 172(1):4-9. DOI:10.1093/aje/kwq119 · 4.98 Impact Factor
Show more

Similar Publications